Magnesium-Related Interventions in Osteoarthritis Management

Magnesium has emerged as a multifaceted agent in the prevention and treatment of osteoarthritis (OA), acting through nutritional, cellular and molecular pathways. Nutritional studies have consistently linked low dietary magnesium intake and suboptimal serum magnesium levels with increased prevalence of knee OA and accelerated joint degeneration. At the cellular level, magnesium modulates inflammation by inhibiting key pro-inflammatory transcription factors and cytokine release, while promoting the chondrogenic differentiation of progenitor cells. Molecular investigations reveal that magnesium deficiency disrupts cartilage homeostasis by impairing autophagy, activating the Wnt/β-catenin pathway and altering subchondral bone remodelling. These insights have prompted the design of magnesium-enriched diets, supplement regimens and biomaterials that release magnesium ions in situ for cartilage repair. Taken together, magnesium-related interventions offer a low-cost, globally applicable strategy to complement pharmacological and surgical approaches in OA management.

Research from Nature Portfolio

In a foundational study, magnesium was shown to inhibit macrophage activation by reducing nuclear translocation and phosphorylation of the inflammatory regulator NF-κB. This dampening of both pro- and anti-inflammatory cytokines in activated macrophages reversed their inhibitory effects on cartilage formation. When conditioned medium from treated macrophages was applied to human bone marrow mesenchymal stem cells in a three-dimensional micromass culture, magnesium restored chondrogenic differentiation, increased extracellular matrix deposition and improved the structural integrity of neo-cartilage. These findings establish a mechanistic link between magnesium’s anti-inflammatory effects and its capacity to enhance stem-cell-mediated cartilage regeneration.

Magnesium-Related Interventions in Osteoarthritis Management publication trend

The graph below shows the total number of articles in magnesium-related interventions in osteoarthritis management across all publications each year (not limited to Nature Index journals).

Technical terms

Chondrogenic differentiation: The process by which mesenchymal stem cells mature into cartilage-producing chondrocytes.

Mesenchymal stem cells: Multipotent progenitor cells found in bone marrow and other tissues that can give rise to bone, cartilage and fat cells.

NF-κB: A transcription factor central to the regulation of immune and inflammatory responses.

Autophagy: A cellular self-digestion mechanism that removes damaged organelles and proteins to maintain homeostasis.

Wnt/β-catenin signalling: A molecular cascade that controls cell proliferation, differentiation and tissue repair; overactivation can lead to cartilage degeneration.

Joint-space narrowing: A radiographic sign of cartilage loss in osteoarthritis, measured as reduced distance between opposing bone surfaces.

Osteophytes: Bony outgrowths or spurs that form at joint margins as a response to cartilage degeneration.

References

1. Magnesium enhances the chondrogenic differentiation of mesenchymal stem cells by inhibiting activated macrophage-induced inflammation. Scientific Reports (2018).
2. The Impact of Trace Elements on Osteoarthritis. Frontiers in Medicine (2021).
3. Association between Dietary Magnesium Intake and Radiographic Knee Osteoarthritis. PLOS ONE (2015).
4. Increased Wnt/β-catenin signaling contributes to autophagy inhibition resulting from a dietary magnesium deficiency in injury-induced osteoarthritis. Arthritis Research & Therapy (2022).